Healthleap Secures $38M for AI Platform Identifying At-Risk Hospital Patients

Healthleap, a startup developing an AI platform designed to analyze patient records and identify individuals at risk of undiagnosed illnesses in hospitals, has successfully raised $38 million in seed and Series A funding. TechCrunch exclusively reported that this financing includes an $8 million seed round co-led by prominent investors Sequoia Capital and First Round Capital, alongside a $30 million Series A round led by Hummingbird Ventures. The company has not disclosed its valuation at this time.

Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, Healthleap initially focused on a clinical nutrition tool for dietitians, developed by Jemima. The company later pivoted to its current, more general-purpose platform. CEO and co-founder Josiah Meyer explained that the platform aims to identify hospital patients who may be suffering from conditions such as malnutrition or delirium, which are frequently not identified early enough. He noted that while structured data like labs and vital signs are present, the most telling signs often reside in clinicians' written notes, such as mentions of poor appetite, recent weight loss, or difficulty swallowing. Healthleap's approach involves extracting these clinical concepts from written notes in an extensible and scalable manner.

The AI platform is currently deployed in over 50 hospitals, where it screens patients for conditions including malnutrition and delirium. Healthleap has also developed programs to identify aspiration pneumonia, pressure ulcers, and the risk of readmission for congestive heart failure, which are undergoing further clinical validation. The system integrates with a hospital’s electronic health record system, utilizing language models to pull pertinent information from written notes. This analysis is then combined with structured data like lab reports and vitals, feeding into risk models that flag patients who may require a closer look. Meyer emphasized that the software highlights potential issues for additional review by the care team, rather than providing diagnoses.

According to Josiah Meyer, Healthleap's system analyzes every adult inpatient’s record each night, including lab results, vital signs, medications, diet orders, and clinicians’ notes. Each morning, a risk score is integrated into the care team’s existing workflow, accessible via a dashboard with additional patient trend information. Malnutrition served as a key starting point, as research indicates 20% to 50% of hospital inpatients are malnourished, a condition linked to longer stays, impaired wound healing, infections, and higher morbidity and mortality. The company has demonstrated significant growth, expanding from three hospital partners to more than 50 over the past year, with customers including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. Revenue has also grown over 10x in the same period.

Healthleap's business model involves selling three-year contracts priced according to a hospital’s licensed bed count, and it also employs an outcome-based pricing model. The company contractually ensures that it delivers multiples of the contract price, based on hard ROI validated by the hospital finance team. To date, every customer has reportedly seen a 5x hard ROI or more, with some cases exceeding 20x annual total ROI. For instance, at the Hospital of the University of Pennsylvania, Healthleap’s malnutrition program generated an annualized financial impact of $23.8 million, comprising $6.3 million from additional reimbursement and $17.5 million from shorter hospital stays.

The fresh capital will be allocated towards expanding engineering, product development, sales, and customer success teams. Healthleap plans to add support for identifying over 40 major health conditions and aims to expand its services into outpatient and home care settings in the future.

What to watch: Healthleap's expansion into identifying more conditions and its growth into outpatient and home care markets.

Editor's note: The draft is a high-quality report that incorporates all financial details, company history, and operational context from the source.